Table 1.
PICO | Inclusion criteria | Exclusion criteria |
---|---|---|
Patients |
Cancer patients (all entities and stages) Adult patients (age > 18) Guideline-based cancer treatment |
Preclinical studies Study population with children or only precancerous conditions, if numeral details are not reported separately Primary prevention |
Intervention |
Every intervention containing homeopathy No restrictions regarding the type of homeopathy, dose, mode of application |
|
Comparison | All possible control groups (active control, placebo, standard care, observation) | |
Outcome |
Influence on toxicity of cancer treatment (skin reaction, nausea and vomiting, joint pain and stiffness, oral mucositis) Time to drain removal Survival Menopausal symptoms Quality of life and other psychological outcomes Sleep Safety and side effects |
No patient centred outcomes (e.g. laboratory parameters) |
Others |
All study types (including SRs, RCTs, CTs, one-armed studies and retrospective studies) Language: German and English Full publication |
Other publication type than primary investigation/report Case reports Gray literature (conference articles, abstracts, comments, letters, ongoing studies, unpublished literature, etc.) Full text not available in German or English |